311 related articles for article (PubMed ID: 33685433)
1. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
[TBL] [Abstract][Full Text] [Related]
2. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
3. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Fu Y; Sun S; Man X; Kong C
PeerJ; 2019; 7():e7854. PubMed ID: 31592165
[TBL] [Abstract][Full Text] [Related]
6. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
Han L; Sun Y; Lu C; Ma C; Shi J; Sun D
Front Genet; 2021; 12():666833. PubMed ID: 34127929
[TBL] [Abstract][Full Text] [Related]
7. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
Zeng Z; Cao Z; Zhang E; Huang H; Tang Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
[TBL] [Abstract][Full Text] [Related]
9. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
10. CDCA8 expression and its clinical relevance in patients with bladder cancer.
Bi Y; Chen S; Jiang J; Yao J; Wang G; Zhou Q; Li S
Medicine (Baltimore); 2018 Aug; 97(34):e11899. PubMed ID: 30142792
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Gao L; Zhao A; Wang X
Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
[TBL] [Abstract][Full Text] [Related]
12. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
Wang J; Huang R; Huang Y; Chen Y; Chen F
Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
Huang C; Zhao J; Luo C; Zhu Z
Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
[No Abstract] [Full Text] [Related]
15. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Wu M; Kim KY; Park WC; Ryu HS; Choi SC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Transl Oncol; 2020 Dec; 13(12):100861. PubMed ID: 32891902
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
Fan X; Wen J; Bao L; Gao F; Li Y; He D
Front Genet; 2021; 12():681809. PubMed ID: 35095994
[TBL] [Abstract][Full Text] [Related]
18. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
[No Abstract] [Full Text] [Related]
19. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
Tang M; Liao M; Ai X; He G
Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
[TBL] [Abstract][Full Text] [Related]
20. CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunology.
Hu H; Umair M; Khan SA; Sani AI; Iqbal S; Khalid F; Sultan R; Abdel-Maksoud MA; Mubarak A; Dawoud TM; Malik A; Saleh IA; Al Amri AA; Algarzae NK; Kodous AS; Hameed Y
Am J Transl Res; 2024; 16(2):432-445. PubMed ID: 38463578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
